Humanoptics AG logo

H9O1 - Humanoptics AG Share Price

€10 0.0  0.0%

Last Trade - 13/04/21

Micro Cap
Market Cap £30.3m
Enterprise Value £30.2m
Revenue £8.13m
Position in Universe 877th / 1046
Unlock H9O1 Revenue
Relative Strength (%)
1m -4.66%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9.00 10.7 11.6 11.1 10.7 9.36 +0.8%
-39.7 +10.7 -81.2
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, HumanOpticsAG revenues decreased 12% to EUR9.4M. Net loss applicableto common stockholders increased 36% to EUR2.6M. Revenuesreflect a decrease in demand for the Company's products andservices due to unfavorable market conditions. Higher netloss reflects Depreciation and Amortization increase of 5%to EUR513K (expense), Social Security Payments and Otherincrease of 2% to EUR1.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


H9O1 Revenue Unlock H9O1 Revenue

Net Income

H9O1 Net Income Unlock H9O1 Revenue

Normalised EPS

H9O1 Normalised EPS Unlock H9O1 Revenue

PE Ratio Range

H9O1 PE Ratio Range Unlock H9O1 Revenue

Dividend Yield Range

H9O1 Dividend Yield Range Unlock H9O1 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
H9O1 EPS Forecasts Unlock H9O1 Revenue
Profile Summary

HumanOptics AG is a Germany-based company that develops, produces and distributes intelligent technology for eye implantation surgery, especially intraocular lenses (IOL). These artificial lenses are implanted into the human eye. Indications for IOL implantations are eye diseases, such as the cataract. Intraocular lenses are also used for refractive surgery to correct refractive errors of the eye causing ametropia. The lenses are distributed under the brand names of Aspira, Diffractiva, Secura and Torica, among others. In addition, the Company offers its target group, the ophthalmic surgeons, accessories and complementary products, as well as consulting services. It operates also a wholly owned subsidiary, Dr. Schmidt Intraocularlinsen GmbH. On February 2, 2012, Medipart AG became majority shareholder of the Company.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Public Since July 11, 2006
No. of Shareholders: n/a
No. of Employees: 127
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Frankfurt Stock Exchange
Shares in Issue 3,487,280
Free Float (0.0%)
Eligible for
View larger map
Address Spardorfer Strasse 150, ERLANGEN, 91054, Germany
Web https://www.humanoptics.com/
Phone +49 9131 506650
Contact ()
H9O1 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for H9O1
Upcoming Events for H9O1
Frequently Asked Questions for Humanoptics AG
What is the Humanoptics AG share price?

As of 13/04/21, shares in Humanoptics AG are trading at €10, giving the company a market capitalisation of £30.3m. This share price information is delayed by 15 minutes.

How has the Humanoptics AG share price performed this year?

Shares in Humanoptics AG are currently trading at €10 and the price has moved by -9.09% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Humanoptics AG price has moved by -28.96% over the past year.

What are the analyst and broker recommendations for Humanoptics AG?

Of the analysts with advisory recommendations for Humanoptics AG, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Humanoptics AG is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Humanoptics AG next release its financial results?

Humanoptics AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Humanoptics AG dividend yield?

Humanoptics AG does not currently pay a dividend.

Does Humanoptics AG pay a dividend?

Humanoptics AG does not currently pay a dividend.

When does Humanoptics AG next pay dividends?

Humanoptics AG does not currently pay a dividend.

How do I buy Humanoptics AG shares?

To buy shares in Humanoptics AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Humanoptics AG?

Shares in Humanoptics AG are currently trading at €10, giving the company a market capitalisation of £30.3m.

Where are Humanoptics AG shares listed? Where are Humanoptics AG shares listed?

Here are the trading details for Humanoptics AG:

Country of listing: Germany
Exchange: FRA
Ticker Symbol: H9O1
What kind of share is Humanoptics AG?

Based on an overall assessment of its quality, value and momentum, Humanoptics AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Humanoptics AG share price forecast 2021?

We were not able to load any forecast data for Humanoptics AG.

How can I tell whether the Humanoptics AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Humanoptics AG. Over the past six months, the relative strength of its shares against the market has been 3.49%. At the current price of €10, shares in Humanoptics AG are trading at 6.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Humanoptics AG PE Ratio?

We were not able to find PE ratio data for Humanoptics AG.

Who are the key directors of Humanoptics AG?

Humanoptics AG's management team is headed by:

Sonja Strauss - CSU
Robert Schaefer - VSU
Eckhard Besuden - SUB
Stefan Huber - EVP
Pierre Billardon - CEO
Who are the major shareholders of Humanoptics AG?

Here are the top five shareholders of Humanoptics AG based on the size of their shareholding:

Similar to H9O1
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.